We use a session cookie and first-party analytics to run this site — no third-party trackers, no ads. Details in our Privacy Policy.
RESEARCH From the Research Desk — The sub-Rs 100 crore acquisition market, sized. Read it →
Home/ Cases/ Pharmaceuticals/ Arch Pharamalabs Limited
● UNDER CIRP

Arch Pharamalabs Limited

Corporate insolvency resolution — proceedings ongoing · source: Live - IBBI EoI

Metals & chemicals manufacturer · public limited company · incorporated 1993 · 31 years old at admission

Sector Pharmaceuticals Bench NCLT Mumbai CIN U24231MH1993PLC150891 Admitted 15 May 2024 Initiated by FC — Bank of Baroda Last process activity 18 Dec 2025 · claims re-verified

Claims — past the ninety-day period. The public announcement set 29 May 2024, and the ninety days from admission that regulation 12 allows ended 13 Aug 2024. A claim filed now must state its reasons for the delay, and it is for Anshul Gupta to accept or reject it. How claims are filed →

Case record

the public record -- figures open below

Corporate insolvency record of Arch Pharamalabs Limited, commenced 15 May 2024, at NCLT Mumbai, initiated by FC Bank of Baroda. Current status: Under CIRP. A Form G invitation for expression of interest is on record; the round closes 08 Apr 2025.

CIN
U24231MH1993PLC150891
Incorporated
1993
Registered State
Maharashtra
NCLT Bench
Mumbai
Initiated by
FC Bank of Baroda
Public Announcement
17 May 2024
EoI Last Date
08 Apr 2025
PRA List Date
18 Apr 2025
Objections By
23 Apr 2025
Commencement
15 May 2024
Sector
Pharmaceuticals
Resolution Professional
Anshul Gupta →
Subscriber access

Full case intelligence is gated

This page's financial detail is available to stressed.in subscribers — for ARCs, PE funds and resolution professionals.

Admitted claims Recovery waterfall & haircut Sector benchmarks Case timeline & professionals Committee of creditors Plan value & CoC vote Intelligence note
See plans →
Just this company — Rs 1,999 · apply for access →

One company, bought outright — yours permanently, including future updates. Subscribe within 30 days and the whole Rs 1,999 comes off your first month, so starting with one case costs nothing against subscribing later.

Questions? WhatsApp us →
Other Pharmaceuticals cases
Kudos Chemie Limited
Resolved
Parabolic Drugs Limited
Resolved
Kandla Energy and Chemicals Limited
Liquidation
Apex Drugs Ltd.
Resolved
Sources, basis and disclaimers → ·
report an error